Shane Aaron Johnson is Sr VP & General Manager of InMed Pharmaceuticals Inc.. Currently has a direct ownership of 304,595 shares of INM, which is worth approximately $1.33 Million. The most recent transaction as insider was on Jan 06, 2022, when has been sold 8,500 shares (Common Stock) at a price of $1.26 per share, resulting in proceeds of $10,710. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 305K
0% 3M change
0% 12M change
Total Value Held $1.33 Million

Shane Aaron Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2022
BUY
Open market or private purchase
$10,710 $1.26 p/Share
8,500 Added 2.71%
304,595 Common Stock
Dec 30 2021
BUY
Open market or private purchase
$10,764 $1.33 p/Share
8,093 Added 2.66%
296,095 Common Stock
Nov 15 2021
BUY
Open market or private purchase
$6,850 $1.37 p/Share
5,000 Added 1.71%
288,002 Common Stock
SAJ

Shane Aaron Johnson

Sr VP & General Manager
Vancouver, A1

Track Institutional and Insider Activities on INM

Follow InMed Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INM shares.

Notify only if

Insider Trading

Get notified when an In Med Pharmaceuticals Inc. insider buys or sells INM shares.

Notify only if

News

Receive news related to InMed Pharmaceuticals Inc.

Track Activities on INM